Free Trial

Psyence Biomedical (PBMWW) Competitors

$0.01 +0.00 (+1.00%)
As of 04/30/2025 03:47 PM Eastern

PBMWW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ACABW, BFRIW, BTMDW, BCTXW, and CELUW

Should you be buying Psyence Biomedical stock or one of its competitors? The main competitors of Psyence Biomedical include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), BriaCell Therapeutics (BCTXW), and Celularity (CELUW). These companies are all part of the "pharmaceutical products" industry.

Psyence Biomedical vs.

180 Life Sciences (NASDAQ:ATNFW) and Psyence Biomedical (NASDAQ:PBMWW) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, profitability, community ranking, analyst recommendations, dividends, earnings, risk, valuation and institutional ownership.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
180 Life SciencesN/AN/AN/AN/AN/A
Psyence BiomedicalN/AN/AN/AN/AN/A

180 Life Sciences and Psyence Biomedical both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
180 Life SciencesN/AN/A
Psyence BiomedicalN/AN/A

In the previous week, 180 Life Sciences had 1 more articles in the media than Psyence Biomedical. MarketBeat recorded 2 mentions for 180 Life Sciences and 1 mentions for Psyence Biomedical. 180 Life Sciences' average media sentiment score of 1.89 beat Psyence Biomedical's score of 1.87 indicating that 180 Life Sciences is being referred to more favorably in the media.

Company Overall Sentiment
180 Life Sciences Very Positive
Psyence Biomedical Very Positive

Company Net Margins Return on Equity Return on Assets
180 Life SciencesN/A N/A N/A
Psyence Biomedical N/A N/A N/A

Summary

180 Life Sciences beats Psyence Biomedical on 2 of the 2 factors compared between the two stocks.

Get Psyence Biomedical News Delivered to You Automatically

Sign up to receive the latest news and ratings for PBMWW and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PBMWW vs. The Competition

MetricPsyence BiomedicalPharmaceutical Preparations IndustryManufacturing SectorNASDAQ Exchange
Market CapN/A$6.90B$2.02B$7.82B
Dividend YieldN/A3.06%2.70%4.22%
P/E RatioN/A7.4422.4718.48
Price / SalesN/A242.7360.32103.91
Price / CashN/A65.8551.7234.62
Price / BookN/A6.512.004.25
Net IncomeN/A$143.21M-$333.48M$248.23M
7 Day PerformanceN/A3.95%2.02%3.29%
1 Month PerformanceN/A0.34%-0.74%2.42%
1 Year PerformanceN/A2.58%7.78%5.54%

Psyence Biomedical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PBMWW
Psyence Biomedical
N/A$0.01
+1.0%
N/A-85.0%$0.00N/A0.00N/APositive News
ATNFW
180 Life Sciences
N/A$0.01
flat
N/A-11.8%$0.00N/A0.007News Coverage
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522,000.000.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.03
+9.1%
N/AN/A$0.00N/A0.002Gap Down
High Trading Volume
AIMDW
Ainos
N/A$0.11
+24.0%
N/AN/A$0.00$20,729.000.0040Gap Down
ALVOW
Alvotech
N/A$1.40
+26.1%
N/A-59.3%$0.00$489.68M0.004Short Interest ↑
News Coverage
Gap Down
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.03
flat
N/A-76.3%$0.00N/A0.0015
BFRIW
Biofrontera
N/A$0.05
-29.5%
N/AN/A$0.00$37.32M0.0070
BTMDW
biote
N/A$0.01
-2.3%
N/A-89.9%$0.00$197.19M0.00N/AGap Down
BCTXW
BriaCell Therapeutics
N/A$0.14
+7.8%
N/A-86.8%$0.00N/A0.008Gap Up
CELUW
Celularity
N/A$0.04
-3.3%
N/A+14.0%$0.00$48.20M0.00220Gap Down

Related Companies and Tools


This page (NASDAQ:PBMWW) was last updated on 5/1/2025 by MarketBeat.com Staff
From Our Partners